Ubs Group Ag Ultragenyx Pharmaceutical Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Ubs Group Ag holds 93,069 shares of RARE stock, worth $4.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

93,069

Previous 195,891 52.49%

Holding current value

$4.16 Million

Previous $8.05 Million 35.8%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.21 - $59.36 $4.13 Million - $6.1 Million	-102,822 Reduced 52.49%	93,069 $5.17 Million
Q2 2024 Aug 13, 2024	BUY	$37.42 - $51.61 $1 Million - $1.38 Million	26,728 Added 15.8%	195,891 $8.05 Million
Q1 2024 May 13, 2024	BUY	$43.02 - $53.69 $4.79 Million - $5.98 Million	111,342 Added 192.56%	169,163 $7.9 Million
Q4 2023 Feb 09, 2024	BUY	$31.73 - $49.19 $362,642 - $562,192	11,429 Added 24.64%	57,821 $2.77 Million
Q3 2023 Nov 09, 2023	SELL	$34.92 - $46.66 $596,363 - $796,859	-17,078 Reduced 26.91%	46,392 $1.65 Million
Q2 2023 Aug 11, 2023	SELL	$37.35 - $52.15 $429,898 - $600,246	-11,510 Reduced 15.35%	63,470 $2.93 Million
Q1 2023 May 12, 2023	SELL	$36.99 - $48.71 $3.33 Million - $4.39 Million	-90,118 Reduced 54.58%	74,980 $3.01 Million
Q4 2022 Feb 08, 2023	BUY	$33.72 - $46.33 $4.57 Million - $6.28 Million	135,455 Added 456.95%	165,098 $7.65 Million
Q3 2022 Nov 10, 2022	SELL	$39.96 - $66.14 $699,539 - $1.16 Million	-17,506 Reduced 37.13%	29,643 $1.23 Million
Q2 2022 Aug 10, 2022	SELL	$45.8 - $85.4 $2.07 Million - $3.86 Million	-45,188 Reduced 48.94%	47,149 $2.81 Million
Q1 2022 May 16, 2022	BUY	$62.2 - $84.4 $1.8 Million - $2.44 Million	28,959 Added 45.69%	92,337 $6.71 Million
Q4 2021 Feb 14, 2022	BUY	$73.71 - $87.86 $530,196 - $631,976	7,193 Added 12.8%	63,378 $5.33 Million
Q3 2021 Nov 15, 2021	BUY	$77.92 - $102.4 $2.38 Million - $3.13 Million	30,559 Added 119.25%	56,185 $5.07 Million
Q2 2021 Aug 13, 2021	SELL	$92.19 - $115.71 $2.21 Million - $2.78 Million	-24,003 Reduced 48.36%	25,626 $2.44 Million
Q1 2021 May 12, 2021	BUY	$106.9 - $167.73 $2.35 Million - $3.69 Million	22,002 Added 79.64%	49,629 $5.65 Million
Q4 2020 Feb 11, 2021	BUY	$84.4 - $177.39 $124,068 - $260,763	1,470 Added 5.62%	27,627 $3.83 Million
Q3 2020 Nov 12, 2020	SELL	$72.98 - $90.0 $405,914 - $500,580	-5,562 Reduced 17.54%	26,157 $2.15 Million
Q2 2020 Jul 31, 2020	SELL	$46.91 - $78.22 $4.65 Million - $7.75 Million	-99,111 Reduced 75.76%	31,719 $2.48 Million
Q1 2020 May 01, 2020	BUY	$33.8 - $62.9 $1.65 Million - $3.07 Million	48,730 Added 59.35%	130,830 $5.81 Million
Q4 2019 Feb 14, 2020	SELL	$36.08 - $45.83 $2.96 Million - $3.76 Million	-82,148 Reduced 50.01%	82,100 $3.51 Million
Q3 2019 Nov 14, 2019	BUY	$42.5 - $63.11 $5.28 Million - $7.84 Million	124,167 Added 309.79%	164,248 $7.03 Million
Q2 2019 Aug 14, 2019	BUY	$54.93 - $74.36 $643,614 - $871,276	11,717 Added 41.31%	40,081 $2.55 Million
Q1 2019 May 14, 2019	SELL	$39.87 - $69.36 $4.84 Million - $8.42 Million	-121,450 Reduced 81.07%	28,364 $1.97 Million
Q4 2018 Feb 14, 2019	BUY	$38.89 - $77.3 $4.21 Million - $8.38 Million	108,380 Added 261.57%	149,814 $6.51 Million
Q3 2018 Nov 14, 2018	BUY	$71.81 - $90.15 $947,892 - $1.19 Million	13,200 Added 46.75%	41,434 $3.16 Million
Q2 2018 Aug 14, 2018	SELL	$48.54 - $85.31 $4.17 Million - $7.33 Million	-85,918 Reduced 75.27%	28,234 $2.17 Million
Q1 2018 May 15, 2018	BUY	$44.33 - $58.52 $4 Million - $5.28 Million	90,294 Added 378.46%	114,152 $5.82 Million
Q4 2017 Feb 14, 2018	SELL	$43.54 - $57.32 $503,409 - $662,733	-11,562 Reduced 32.64%	23,858 $1.11 Million
Q3 2017 Nov 14, 2017	BUY	$49.79 - $66.32 $901,099 - $1.2 Million	18,098 Added 104.48%	35,420 $1.89 Million
Q2 2017 Aug 14, 2017	BUY	N/A	7,608 Added 78.32%	17,322 $1.08 Million
Q1 2017 Nov 14, 2017	BUY	N/A	9,714	9,714 $658,000

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.13B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account